Drug or technology
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a Phase 1 safety and feasibility trial in a neurodegenerative disease population with no results yet posted; it is designed to generate early evidence on tolerability and enrollment, not to establish efficacy.
AUG 13, 2026 · PHASE EARLY PHASE 1 TRIAL
ClinicalTrials.gov
This is an early-phase pilot study registration with no results posted; it describes planned enrollment and methods only, insufficient to assess efficacy or safety outcomes.